3 July 2024
Latham Advises on Financing for Frazier Healthcare Partners’ Completed Acquisition of BioMatrix
Advising firms
Deal team
11 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Stelios Saffos Lead | Latham & Watkins LLP | Partner | Not stated | New York |
| Peter Sluka Lead | Latham & Watkins LLP | Partner | Not stated | New York |
| John Lister | Latham & Watkins LLP | Partner | Not stated | Chicago |
| Jason Bosworth | Latham & Watkins LLP | Partner | Not stated | Los Angeles |
| Jeff Senac | Latham & Watkins LLP | Partner | Not stated | Los Angeles |
| Bryce Kaufman | Latham & Watkins LLP | Counsel | Not stated | Houston |
| Sean Travers | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Bora Bozkurt | Latham & Watkins LLP | Partner | tax | New York |
| Sam Yang | Latham & Watkins LLP | Associate | tax | Not stated |
| Nicole Liffrig Molife | Latham & Watkins LLP | Counsel | healthcare regulatory | Washington, D.C. |
| Ben Rosemergy | Latham & Watkins LLP | Partner | employee benefits | Chicago |
8 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- private credit lendersLenders
- Counterparties
- Frazier Healthcare Partners (Buy-side)
BioMatrix Holdings, LLC (Target)